Use of scyllo-inositols for the treatment of macular degeneration-related disorders

Details for Australian Patent Application No. 2009301603 (hide)

Owner Waratah Pharmaceuticals Inc.

Inventors Cruz, Antonio

Agent Peter Maxwell & Associates

Pub. Number AU-A-2009301603

PCT Pub. Number WO2010/040232

Priority 61/104,094 09.10.08 US

Filing date 9 October 2009

Wipo publication date 15 April 2010

International Classifications

A61K 31/047 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/040232 Priority application(s): WO2010/040232

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009301605-Methods for the classification and diagnosis of scoliosis through the use of Gi protein receptor

2009301600-Wind powered apparatus having counter rotating blades